Spine Biologics Market Size is expected to increase to USD 280 Billion by 2023, globally.
In the year 2018 Global Spine Biologics Market was valued at USD 226 billion. By the year 2023, it is predicted to reach USD 280 billion with pace of 4.4% CAGR.
Spine is one of the most important support systems in the human body that enables the body to bend, twist, and safeguard spinal cord. Spine biologics are used in the treatment of spine trauma, tumors, and degenerative diseases by stimulating bone growth formation through the repair stage, remodeling stage, and inflammatory stage. Spine Biologics helps in active cellular growth and fast recovery.
Request Report Sample: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/request-sample
Factors affecting market growth:
• Growing of geriatric population across the globe. (+)
• Increasing adoption of minimally invasive surgeries. (+)
• Rise in prevalence of chronic diseases. (+)
• Increasing investments by government. (+)
• Advancement of technologies. (+)
• Introduction of new techniques for treating spine cord disorders. (+)
• Increasing healthcare expenditures. (+)
• Lack of skilled professionals. (-)
• Unfavorable reimbursement policies. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/customize-report
Market Segmentation
The Global Spine Biologics Market is segmented on the basis of
Surgery type
• Anterior Cervical Discectomy and Fusion
• Posterior Lumbar Interbody Fusion
• Transforaminal Lumbar Interbody Fusion
• Anterior Lumbar Interbody Fusion
• Lateral Lumbar Interbody Fusion
Product type
• Bone graft
(Autograft, Allograft)
• Bone graft substitutes
(Synthetic bone grafts, Demineralized bone matrix, Bone Morphogenetic proteins)
• Platelet rich plasma
• Bone marrow aspitaye therapy.
Based on surgery type market, Anterior Cervical Discectomy and Fusion segment holds the largest market share in the global spine biologics market. On basis of product type market the bone grafts substitutes segment is expected to register a high growth rate in the global spine biologics market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/
Key players:
Leading companies for Global Spine Biologics Market are Orthofix International N.V., RTI Surgical, Inc., SeaSpine, Zimmer Biomet Holdings, Inc., Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., and Medtronic plc, NuVasive, Inc.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Spine is one of the most important support systems in the human body that enables the body to bend, twist, and safeguard spinal cord. Spine biologics are used in the treatment of spine trauma, tumors, and degenerative diseases by stimulating bone growth formation through the repair stage, remodeling stage, and inflammatory stage. Spine Biologics helps in active cellular growth and fast recovery.
Request Report Sample: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/request-sample
Factors affecting market growth:
• Growing of geriatric population across the globe. (+)
• Increasing adoption of minimally invasive surgeries. (+)
• Rise in prevalence of chronic diseases. (+)
• Increasing investments by government. (+)
• Advancement of technologies. (+)
• Introduction of new techniques for treating spine cord disorders. (+)
• Increasing healthcare expenditures. (+)
• Lack of skilled professionals. (-)
• Unfavorable reimbursement policies. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/customize-report
Market Segmentation
The Global Spine Biologics Market is segmented on the basis of
Surgery type
• Anterior Cervical Discectomy and Fusion
• Posterior Lumbar Interbody Fusion
• Transforaminal Lumbar Interbody Fusion
• Anterior Lumbar Interbody Fusion
• Lateral Lumbar Interbody Fusion
Product type
• Bone graft
(Autograft, Allograft)
• Bone graft substitutes
(Synthetic bone grafts, Demineralized bone matrix, Bone Morphogenetic proteins)
• Platelet rich plasma
• Bone marrow aspitaye therapy.
Based on surgery type market, Anterior Cervical Discectomy and Fusion segment holds the largest market share in the global spine biologics market. On basis of product type market the bone grafts substitutes segment is expected to register a high growth rate in the global spine biologics market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/spine-biologics-market-4275/
Key players:
Leading companies for Global Spine Biologics Market are Orthofix International N.V., RTI Surgical, Inc., SeaSpine, Zimmer Biomet Holdings, Inc., Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., and Medtronic plc, NuVasive, Inc.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626